Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 56

Tests names and labsConditionsGenes and analytesMethods

CentoICU platinum

Centogene AG - the Rare Disease Company
Germany
768514
  • C Sequence analysis of the entire coding region

CentoICU platinum plus

Centogene AG - the Rare Disease Company
Germany
768514
  • C Sequence analysis of the entire coding region

Polycystic kidney panel

Centogene AG - the Rare Disease Company
Germany
55
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Polycystic kidney disease type 2, AD

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

KidneySeq: A Comprehensive Inherited Kidney Disease Panel

Iowa Institute of Human Genetics University of Iowa
United States
122147
  • C Sequence analysis of the entire coding region

Polycystic Liver Disease (PLD) NextGen Sequencing (NGS) Panel

PreventionGenetics
United States
35
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Autosomal Dominant and Recessive Polycystic Kidney Disease NextGen Sequencing (NGS) Panel

PreventionGenetics
United States
44
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Autosomal Dominant Polycystic Kidney Disease Sequencing Panel

PreventionGenetics
United States
33
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

TruGenome Predisposition Screen (Whole Genome Sequencing)

Illumina Clinical Services Laboratory Illumina
United States
15411578
  • C Sequence analysis of the entire coding region

PKD2. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

Autosomal dominant polycystic kidney disease via the PKD2 Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Renal Cystic Disorders Sequencing Panel

Genetic Services Laboratory University of Chicago
United States
1263
  • C Sequence analysis of the entire coding region

POLYCYSTIC KIDNEY

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
33
  • C Sequence analysis of the entire coding region

Invitae Polycystic Kidney Disease Panel

Invitae
United States
42
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Autosomal dominant polycystic kidney disease type 2

Bioarray
Spain
11
  • C Sequence analysis of the entire coding region

Polycystic Kidney Disease, Autosomal Dominant (PKD1 and PKD2) Sequencing and Deletion/Duplication

ARUP Laboratories, Molecular Genetics University of Utah ARUP Lab
United States
12
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Polycystic Kidney Disease, Autosomal Dominant (PKD1 and PKD2) Sequencing

ARUP Laboratories, Molecular Genetics University of Utah ARUP Lab
United States
12
  • C Sequence analysis of the entire coding region

Polycystic Kidney Disease, Autosomal Dominant (PKD1 and PKD2) Deletion/Duplication

ARUP Laboratories, Molecular Genetics University of Utah ARUP Lab
United States
12
  • D Deletion/duplication analysis

Ciliopathies (NGS panel for 90 genes)

CGC Genetics
Portugal
190
  • C Sequence analysis of the entire coding region

PKD2 - Polycystic Kidney Disease

Medizinisch Genetisches Zentrum München MGZ München
Germany
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 56

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.